IDEAYA Biosciences to Participate in Upcoming February 2026 Investor Relations Events

Group 1 - IDEAYA Biosciences, Inc. is participating in two upcoming investor relations events, including Citi's 2026 Virtual Oncology Leadership Summit on February 18, 2026, and a Virtual Fireside Chat on February 23, 2026 [1] - The company focuses on precision medicine in oncology, aiming to discover and develop targeted therapeutics for cancer treatment [2] - IDEAYA has a robust pipeline of product candidates, particularly in synthetic lethality and antibody-drug conjugates (ADCs), targeting molecularly defined solid tumor indications [2] Group 2 - The company integrates expertise in small-molecule drug discovery, structural biology, and bioinformatics to develop tailored therapies aligned with genetic disease drivers [2] - IDEAYA's mission is to create the next wave of precision oncology therapies that are more selective, effective, and personalized, with the goal of improving clinical outcomes for cancer patients [2]